NOTE :

We are currently translating the 2009-2010 "Medical Management of HIV Infection" into a web-ready format. We will post each chapter as it is completed. To make any comments or suggestions click here

Previous         51         Next
dkfhkd

Discussion Thread

in persons with HIV infection. A meta-analysis showed the TST had good sensitivity except in patients with prior BCG and IGRA was preferred in that population (Ann Intern Med 2007;146:340).. Studies to determine relative merits of these tests to detect latent TB in persons with HIV infection are ongoing (Ann Intern Med 2007; 146:340). 

Pap Smear: The CDC recommends that a gynecological evaluation with pelvic exam and Pap smear be performed at baseline, repeated at 6 months and annually thereafter (MMWR 2002;517[RR-6]:59; JAMA 1994;271:1866; MMWR 1999;48[RR-10]:31), with management according to guidelines in Table 2-27 (below). More aggressive test ing is recommended because of a several-fold increase in rates of squamous intra epithelial lesion (SIL) (33% to 45% HIV+ vs 7% to 14% HIV-) and a 0- to 9-fold increase in rates of cervical cancer in women with HIV (Arch Pediatr Adolesc Med 2000;154:127; Obstet Gynecol Clin N Am 1996; 23,861; JAIDS 2003;32:527; JAIDS 2004;36:978). Severity and frequency of cervical dysplasia increase with progressive immune compro - mise. There is a strong association between HIV infection and detectable and per sistent HPV infection by HPV types associated with cervical

TABLE 2-17:

Recommendations for Intervention Based on Results of Pap Smear (MMWR 2006;RR-11:1-94 JAMA 1989;262:931; JAMA 2002;287:2114)

Results Management
Severe inflammation Evaluate for infection; repeat Pap smear,
preferably within 2 to 3 months.
Atypia, atypical squamous cells of
undetermined significance (ASCUS)
  • ASC-US (undetermined significance)
  • ASC-H (cannot exclude HSIL). ASC-H is intermediate between ASC-US and HSIL
  • ACG (atypical glandular cells)
  • Refer for culposcopy
  • ASC-US: HPV testing may be used to help with management (Am J Obstet Gynec 2007;197:346). If culposcopy was adequate and no biopsy confirmed CIN: repeat culposcopy at 12 months and 24 months. If negative resume annual screening.
  • ASC-H: Cytolotic follow-up at 6 and 12 mo. With kASC-US or greater on repeat cytology: repeat colposcopy.
  • AGC: Colposcopy plus endometrial sampling; women >35 yrs should have endocervical sampling.
Low-grade squamous intraepithelial
lesion (LSIL)
Colposcopy : If satisfactory, exam was
adequate and no lesion or CIN found:
repeat cytology at 6 and 12 mo with colpos -
co py and biopsy if repeat smears are
abnormal.*
High-grade squamous intraepithelial
lesion (HSIL) (carcinoma in situ)
Referral for colposcopy or loop electro
surgical excision.
Invasive carcinoma Colposcopy with biopsy or conization; treat
with surgery or radiation.

* Most gynecologists recommend evaluation with any abnormality due to the high prevalence of underlying SIL.

Chapter 2: Laboratory Tests

Page 51 of 58 (0 Posts)

Add Thread | View All Threads

 

ImagesThreadsNamePostsDate

No Threads...